We are live on ! Find out more
O

Ossiam Portfolio holdings

AUM $5.69B
1-Year Est. Return 30.95%
This Fund
S&P 500
This Quarter Est. Return
+5.38%
1 Year Est. Return
+30.95%
3 Year Est. Return
+104.81%
5 Year Est. Return
+127.55%
10 Year Est. Return
AUM
$5.01B
AUM Growth
-$2.76B
Cap. Flow
-$2.89B
Cap. Flow %
-57.77%
Top 10 Hldgs %
54.39%
Holding
724
New
30
Increased
114
Reduced
213
Closed
336

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$142M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$85.2M
3
COST icon
Costco
COST
+$70.1M
4
MA icon
Mastercard
MA
+$47.4M
5
PLTR icon
Palantir
PLTR
+$46.9M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$291M
2
INTC icon
Intel
INTC
+$278M
3
MSFT icon
Microsoft
MSFT
+$259M
4
AAPL icon
Apple
AAPL
+$200M
5
MSTR icon
Strategy Inc
MSTR
+$79.7M

Sector Composition

Rank Sector Weight
1 Technology 41.39%
2 Consumer Discretionary 24.24%
3 Financials 15.92%
4 Communication Services 6.28%
5 Healthcare 4.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZBH icon
251
Zimmer Biomet
ZBH
$17.7B
$719K 0.01%
7,994
+4,017
+101% +$381K
CBOE icon
252
Cboe Global Markets
CBOE
$29.8B
$716K 0.01%
2,852
-5,458
-66% -$1.36M
ALNY icon
253
Alnylam Pharmaceuticals
ALNY
$36.3B
$710K 0.01%
1,786
+230
+15% +$102K
TLN
254
Talen Energy Corp
TLN
$17.2B
$707K 0.01%
+1,885
New +$733K
TKO icon
255
TKO Group
TKO
$13.5B
$697K 0.01%
+3,337
New +$649K
BRBR icon
256
BellRing Brands
BRBR
$1.51B
$695K 0.01%
26,000
BMRN icon
257
BioMarin Pharmaceuticals
BMRN
$11.5B
$693K 0.01%
11,666
-5,791
-33% -$315K
BNT
258
Brookfield Wealth Solutions
BNT
$11.6B
$686K 0.01%
14,877
-33,654
-69% -$1.53M
FTV icon
259
Fortive
FTV
$19B
$675K 0.01%
12,227
-8,370
-41% -$434K
CDW icon
260
CDW
CDW
$17.1B
$674K 0.01%
4,951
-25,059
-84% -$3.69M
GFL icon
261
GFL Environmental
GFL
$14.3B
$673K 0.01%
15,637
-12,845
-45% -$574K
STE icon
262
Steris
STE
$20.9B
$660K 0.01%
2,605
-254
-9% -$63.8K
NWS icon
263
News Corp Class B
NWS
$16.4B
$660K 0.01%
22,277
-6,373
-22% -$190K
DD icon
264
DuPont de Nemours
DD
$18.6B
$657K 0.01%
5,450
-76,327
-93% -$8.59M
IR icon
265
Ingersoll Rand
IR
$33B
$649K 0.01%
8,187
+4,999
+157% +$395K
AMH icon
266
American Homes 4 Rent
AMH
$12B
$648K 0.01%
20,191
-4,013
-17% -$129K
AMP icon
267
Ameriprise Financial
AMP
$46.8B
$635K 0.01%
1,295
-1,331
-51% -$632K
ACGL icon
268
Arch Capital
ACGL
$36.1B
$630K 0.01%
6,564
-5,348
-45% -$489K
ZS icon
269
Zscaler
ZS
$23B
$626K 0.01%
2,782
-1,058
-28% -$299K
GLPI icon
270
Gaming and Leisure Properties
GLPI
$12.8B
$623K 0.01%
13,943
+1,919
+16% +$85.1K
COR icon
271
Cencora
COR
$60.3B
$612K 0.01%
1,812
-2,467
-58% -$841K
IEX icon
272
IDEX
IEX
$16.5B
$611K 0.01%
3,435
-1,412
-29% -$241K
INVH icon
273
Invitation Homes
INVH
$17.7B
$611K 0.01%
21,980
-413
-2% -$11.5K
WRB icon
274
W.R. Berkley
WRB
$28B
$600K 0.01%
8,552
-5,449
-39% -$402K
AME icon
275
Ametek
AME
$55.5B
$600K 0.01%
2,920
-321
-10% -$62.5K

Similar funds

Ossiam's Q4 2025 Portfolio in Review

As of Q4 2025, Ossiam held 724 positions worth $5.01B, down 36% from $7.77B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Ossiam withdrew a net $2.89B in Q4 2025, closing 336 positions and reducing 213 holdings. Its most notable exit was Intel, an estimated $278M position sold in full.

By sector, the portfolio is most concentrated in Technology at 41% of assets, down from 45% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Ossiam opened a new position in ExxonMobil worth $7.98M.

  • Ossiam's largest Q4 2025 buy was ExxonMobil: 66,334 shares worth $7.98M.
  • Ossiam added most to Advanced Micro Devices in Q4 2025, an estimated $142M increase.
  • Ossiam's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $291M.
  • Ossiam fully exited Intel in Q4 2025, selling an estimated $278M.
  • Ossiam's ten largest holdings make up 54% of its $5.01B portfolio in Q4 2025.
  • Ossiam opened 30 new positions and closed 336 in Q4 2025.
  • Ossiam's portfolio value fell 36% quarter-over-quarter to $5.01B.

Based on Ossiam's 13F filing for Q4 2025, filed 13 Feb 2026.